Identification of immunodominant T cell epitopes induced by natural Zika virus infection.
Saved in:
| Title: | Identification of immunodominant T cell epitopes induced by natural Zika virus infection. |
|---|---|
| Authors: | Eickhoff CS; Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States., Meza KA; Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States., Terry FE; EpiVax, Inc., Providence, RI, United States., Colbert CG; Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States., Blazevic A; Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States., Gutiérrez AH; EpiVax, Inc., Providence, RI, United States., Stone ET; Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States., Brien JD; Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States., Pinto AK; Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States., El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, United States., Mulligan MJ; New York University Grossman School of Medicine, Division of Infectious Diseases and Immunology, New York, NY, United States., Rouphael N; Emory University School of Medicine, Division of Infectious Diseases, Department of Internal Medicine, Atlanta, GA, United States., Alcaide ML; University of Miami, Division of Infectious Diseases, Miller School of Medicine, Miami, FL, United States., Tomashek KM; Division of Microbiology, Immunology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD, United States., Focht C; The Emmes Company, LLC., Rockville, MD, United States., Martin WD; EpiVax, Inc., Providence, RI, United States., Moise L; EpiVax, Inc., Providence, RI, United States., De Groot AS; EpiVax, Inc., Providence, RI, United States.; University of Georgia Center for Vaccines and Immunology, Athens, GA, United States., Hoft DF; Department of Internal Medicine, Saint Louis University, Division of Infectious Diseases, Allergy, and Immunology, Saint Louis, MO, United States.; Department of Molecular Microbiology and Immunology, Saint Louis University, Saint Louis, MO, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2023 Aug 29; Vol. 14, pp. 1247876. Date of Electronic Publication: 2023 Aug 29 (Print Publication: 2023). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
